AstraZeneca COVID vaccine linked with small risk of low blood platelets, claims new study

The team, led by researchers at the University of Edinburgh in the UK, noted that people at most risks from ITP tended to be older — a median age of 69 years old — and had at least one underlying chronic health problem such as coronary heart disease, diabetes or chronic kidney disease.